NCT05237947 2026-03-19PRISMANational Cancer Institute (NCI)Phase 4 Active not recruiting5,000 enrolled
NCT06639074 2025-10-02Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT TrialMayo ClinicPhase 2 Recruiting78 enrolled